JAK2 mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms.
暂无分享，去创建一个
M. Gassmann | A. Lane | N. Kröger | C. Beisel | Serena Di Palma | C. Hess | J. Trebicka | R. Skoda | T. Fan | S. Koschmieder | C. Handschin | S. Rai | F. Geier | T. Radimerski | D. Wolf | S. Dimeloe | V. Čokić | S. Dirnhofer | R. Nienhold | D. Leković | N. Andina | N. Hansen | Julien Delezie | Julian Hilfiker | Deniz Gezer | S. Galli | Julia Majewska | Hui Hao-Shen | Tata Nageswara Rao | Teresa A. Cassel | Thomas Radimerski | Nicola Andina